Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Randomised Clinical Trial of Therapeutic Interventions to Assess the Effects on Outcome in Adults With Acute Myeloid Leukaemia and High Risk Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation.

NCT04217278 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04217278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04217278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Randomised Clinical Trial of Therapeutic Interventions to Assess the Effects on Outcome in Adults With Acute Myeloid Leukaemia and High Risk Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation.
Lead sponsor
University of Birmingham
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
January 27, 2020
Completion date
May 31, 2026
Enrollment
333 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia, high-risk myelodysplastic syndrome